
Google is challenging a record European Union antitrust fine that took aim at the Android operating system’s role in restricting mobile competition and consumer choice, reported The Seattle Times.
The company said Thursday that it filed the appeal against the 4.125 billion euro ($4.3 billion) penalty “because there are areas that require legal clarification from the European Court of Justice,” the EU’s top court.
Google previously appealed to a lower tribunal, which had slightly lowered the original 4.34 billion-euro penalty in a decision largely siding with the European Commission. It’s the largest-ever antitrust fine issued by the commission, the 27-nation bloc’s top competition watchdog.
Read more: Russian Court Upholds $33M Google Fine
In its 2018 decision, the commission found that the dominance of Google’s Android resulted in less competition and consumer choice. The U.S. tech giant had argued that free and open-source Android resulted in cheaper phones and spurred competition with its chief rival, Apple. Android is the most popular mobile operating system, beating Apple’s iOS.
“Android has created more choice for everyone, not less, and supports thousands of successful businesses in Europe and around the world,” Google said Thursday.
The fine was one of three blockbuster antitrust penalties that the commission hit Google with between 2017 and 2019, highlighting the bloc’s early role in cracking down on tech giants.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas